N4P.L

N4 Pharma Plc N4P.L

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode N4P.L POLX.L FUM.L AGL.L PRM.L TCF.L SUN.L CHLL.L FDBK.L CIZ.L
6M 60.00 % -60.00 % -73.28 % -78.13 % -29.27 % -6.67 % 15.00 % 6 411.63 % -36.31 % 0.00 %
YTD 14.29 % -69.92 % -92.33 % -84.78 % -42.79 % -60.00 % -4.17 % 6 411.63 % -44.80 % -3.13 %
1Y 0.00 % -70.37 % -92.77 % -77.42 % -29.53 % -71.03 % -4.17 % 6 411.63 % -81.52 % -20.51 %
3Y -80.00 % -99.08 % -94.00 % -96.63 % -56.78 % -95.53 % -66.18 % -50.00 % -89.80 % -1.59 %
5Y -90.91 % -99.38 % -83.38 % -96.58 % -50.13 % -98.40 % -62.90 % -96.81 % -94.83 % -83.47 %
10Y -80.65 % -97.07 % -90.68 % -97.86 % -89.19 % -99.39 % -48.89 % -90.18 % -98.10 % -83.47 %
From the beginning -99.96 % -97.07 % -96.61 % -98.83 % -98.73 % -99.39 % -98.07 % -89.02 % -99.93 % -83.47 %

Dividend

N4 Pharma Plc

Feedback plc